| 1 |
32403270 | The Antiproliferative Effects of Flavonoid MAO Inhibitors on Prostate Cancer Cells. | 2020 May 11 |
1 |
| 2 |
19890267 | Reversible inhibitors of monoamine oxidase-A (RIMAs): robust, reversible inhibition of human brain MAO-A by CX157. | 2010 Feb |
1 |
| 3 |
14697899 | Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation. | 2004 Jan |
1 |
| 4 |
11294480 | Predictors of treatment response in patients with posttraumatic stress disorder. | 2001 Feb |
1 |
| 5 |
10410765 | Moclobemide in patients with dementia and depression. | 1999 |
1 |
| 6 |
9273760 | [Poisoning with a reversible and selective monoaminooxidase inhibitor]. | 1997 Aug 4 |
1 |
| 7 |
7905288 | Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide. | 1993 Nov |
1 |
| 8 |
1347658 | Efficacy of moclobemide in different patient groups: a meta-analysis of studies. | 1992 |
1 |
| 9 |
1546143 | Biochemistry and pharmacology of moclobemide, a prototype RIMA. | 1992 |
2 |
| 10 |
1904620 | [Multicenter study comparing efficacy and tolerance of moclobemide and fluvoxamine in hospitalized and ambulatory patients with severe depressive episodes]. | 1991 May 7 |
1 |
| 11 |
2123366 | Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase-A, compared with other antidepressants and placebo. | 1990 |
1 |